Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Detection of MPL mutations by a novel allele-specific PCR-based strategy.

Furtado LV, Weigelin HC, Elenitoba-Johnson KS, Betz BL.

J Mol Diagn. 2013 Nov;15(6):810-8. doi: 10.1016/j.jmoldx.2013.07.006. Epub 2013 Aug 28.

PMID:
23994117
[PubMed - indexed for MEDLINE]
2.

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

Boyd EM, Bench AJ, Goday-Fernández A, Anand S, Vaghela KJ, Beer P, Scott MA, Bareford D, Green AR, Huntly B, Erber WN.

Br J Haematol. 2010 Apr;149(2):250-7. doi: 10.1111/j.1365-2141.2010.08083.x. Epub 2010 Feb 11.

PMID:
20151976
[PubMed - indexed for MEDLINE]
3.

Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.

Glembotsky AC, Korin L, Lev PR, Chazarreta CD, Marta RF, Molinas FC, Heller PG.

Eur J Haematol. 2010 May;84(5):398-405. doi: 10.1111/j.1600-0609.2010.01421.x. Epub 2010 Jan 22.

PMID:
20113333
[PubMed - indexed for MEDLINE]
4.

JAK2 V617F and MPL W515L/K mutations in Korean patients with essential thrombocythemia.

Kim HJ, Jang JH, Yoo EH, Kim HJ, Ki CS, Kim JW, Kim SH.

Korean J Lab Med. 2010 Oct;30(5):474-6. doi: 10.3343/kjlm.2010.30.5.474. Erratum in: Korean J Lab Med. 2010 Dec;30(6):734.

PMID:
20890078
[PubMed - indexed for MEDLINE]
Free Article
5.

MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on TaqMan MGB probes.

Ruan GR, Jiang B, Li LD, Niu JH, Li JL, Xie M, Qin YZ, Liu YR, Huang XJ, Chen SS.

Hematol Oncol. 2010 Mar;28(1):33-9. doi: 10.1002/hon.899.

PMID:
19274616
[PubMed - indexed for MEDLINE]
6.

JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.

Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H.

Exp Hematol. 2009 Oct;37(10):1186-1193.e7. doi: 10.1016/j.exphem.2009.07.005. Epub 2009 Jul 17.

PMID:
19616600
[PubMed - indexed for MEDLINE]
7.

Identification of MPL W515L/K mutations in patients with primary myelofibrosis and essential thrombocythaemia by allele-specific polymerase chain reaction.

Daly S, Conneally E, Langabeer SE.

Acta Haematol. 2009;121(4):221-2. doi: 10.1159/000224333. Epub 2009 Jun 10. No abstract available.

PMID:
19521067
[PubMed - indexed for MEDLINE]
8.

Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia.

Dos Santos LC, Ribeiro JC, Silva NP, Cerutti J, da Silva MR, Chauffaille Mde L.

Rev Bras Hematol Hemoter. 2011;33(6):417-24. doi: 10.5581/1516-8484.20110116.

PMID:
23049357
[PubMed]
Free PMC Article
9.

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Schönegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R.

N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.

PMID:
24325356
[PubMed - indexed for MEDLINE]
Free Article
10.

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

Beer PA, Campbell PJ, Scott LM, Bench AJ, Erber WN, Bareford D, Wilkins BS, Reilly JT, Hasselbalch HC, Bowman R, Wheatley K, Buck G, Harrison CN, Green AR.

Blood. 2008 Jul 1;112(1):141-9. doi: 10.1182/blood-2008-01-131664. Epub 2008 May 1.

PMID:
18451306
[PubMed - indexed for MEDLINE]
Free Article
11.

MPL W515L mutation in Chinese patients with myeloproliferative diseases.

Xu W, Li JY, Xia J, Zhang SJ, Fan L, Qiao C.

Leuk Lymphoma. 2008 May;49(5):955-8. doi: 10.1080/10428190802035966.

PMID:
18464114
[PubMed - indexed for MEDLINE]
12.

A multiplexed fragment analysis-based assay for detection of JAK2 exon 12 mutations.

Furtado LV, Weigelin HC, Elenitoba-Johnson KS, Betz BL.

J Mol Diagn. 2013 Sep;15(5):592-9. doi: 10.1016/j.jmoldx.2013.04.006. Epub 2013 Jun 28.

PMID:
23810504
[PubMed - indexed for MEDLINE]
Free Article
13.

A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction.

Pancrazzi A, Guglielmelli P, Ponziani V, Bergamaschi G, Bosi A, Barosi G, Vannucchi AM.

J Mol Diagn. 2008 Sep;10(5):435-41. doi: 10.2353/jmoldx.2008.080015. Epub 2008 Jul 31.

PMID:
18669880
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prevalence of MPL W515L/K mutations in Taiwanese patients with Philadelphia-negative chronic myeloproliferative neoplasms.

Lieu CH, Shen YJ, Lai WC, Tsai WH, Hsu HC.

J Chin Med Assoc. 2010 Oct;73(10):530-2. doi: 10.1016/S1726-4901(10)70115-5.

PMID:
21051030
[PubMed - indexed for MEDLINE]
15.

Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms.

Pietra D, Brisci A, Rumi E, Boggi S, Elena C, Pietrelli A, Bordoni R, Ferrari M, Passamonti F, De Bellis G, Cremonesi L, Cazzola M.

Haematologica. 2011 Apr;96(4):607-11. doi: 10.3324/haematol.2010.034793. Epub 2011 Jan 12.

PMID:
21228032
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.

Ma W, Zhang X, Wang X, Zhang Z, Yeh CH, Uyeji J, Albitar M.

Diagn Mol Pathol. 2011 Mar;20(1):34-9. doi: 10.1097/PDM.0b013e3181ecd261.

PMID:
21326037
[PubMed - indexed for MEDLINE]
17.

Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.

Williams DM, Kim AH, Rogers O, Spivak JL, Moliterno AR.

Exp Hematol. 2007 Nov;35(11):1641-6. Epub 2007 Oct 17.

PMID:
17920755
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Ligand-independent thrombopoietin mutant receptor requires cell surface localization for endogenous activity.

Marty C, Chaligné R, Lacout C, Constantinescu SN, Vainchenker W, Villeval JL.

J Biol Chem. 2009 May 1;284(18):11781-91. doi: 10.1074/jbc.M808703200. Epub 2009 Mar 4.

PMID:
19261614
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

JAK2 V617F, MPL W515L and JAK2 Exon 12 Mutations in Chinese Patients with Primary Myelofibrosis.

Xia J, Lu MZ, Jiang YQ, Yang GH, Zhuang Y, Sun HL, Shen YF.

Chin J Cancer Res. 2012 Mar;24(1):72-6. doi: 10.1007/s11670-012-0072-4.

PMID:
23359764
[PubMed]
Free PMC Article
20.

MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms.

Akpınar TS, Hançer VS, Nalçacı M, Diz-Küçükkaya R.

Turk J Haematol. 2013 Mar;30(1):8-12. doi: 10.4274/tjh.65807. Epub 2013 Mar 5.

PMID:
24385746
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk